News Detail
![](pdf/bupimine_heavy261224075513.jpg)
Srinagar, 26 Dec 2024: The Jammu and Kashmir government has directed all the hospitals to stop using an anaesthetic drug after it allegedly caused kidney failure, bradycardia (abnormal heart rhythm) and neurological disorders among patients in the valley.
The drug Bupi......
View Details
Source : Etv Bharat
JAMMU KASHMIR
JK GOVT MEDICINE SUPPLY
BMO SOPORE
CMO BARAMULLA
JKMSCL
ANESTHETIC DRUG SUPPLIED TO JK HOSPITALS CAUSES RENAL FAILURE NEUROLOGICAL DISORDERS
Related News
- Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)
- Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)
- FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)
- Dabur sues Patanjali over toothpaste trade dress (16-01-2025)
- Wrappers of drug brands found from Paonta printing press premises (16-01-2025)
- PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)
- Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)
- Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)
- SC warns States/UTs of Contempt Proceedings over inaction on Misleading Advertisements (16-01-2025)
- 3600 Proxyvon capsule consignment going to Nepal caught (15-01-2025)